TrueBeam therapy is a precise and powerful cancer treatment. Combining the technology of radiotherapy and radiosurgery, TrueBeam is another option in the wide range of cancer treatments offered by Penn Medicine. Penn radiation oncologists are using this therapy to treat lung, brain and bone tumors and metastatic cancers.

TrueBeam delivers a prescribed radiation dose from nearly any angle. It combines imaging and beam delivery with technology that rotates around patients to accurately and precisely target tumors with great speed. Real-time imaging tools allow clinicians to "see" the tumor they are treating and respiratory gating enables clinicians to synchronize beam delivery with patients' breathing.

Like other forms of radiation therapy, TrueBeam therapy delivers a radiation dose that damages the cancer cells and prevents them from multiplying. After treatment, the tumor stops growing and, in many cases, it disappears over time.

The Advantage to Patients

One of the most advanced radiation therapies available, TrueBeam's advantages include:
  • Integrated imaging, beam delivery and motion management result in improved operation, precision and speed of treatment
  • Improved image guidance for delivering radiation precisely to the tumor

Types of Cancer Treated with TrueBeam

Like many cancer therapies, TrueBeam is not appropriate for treating all types of cancer. Currently, TrueBeam is being used by Penn Radiation Oncology to treat: